Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Ahmad, Nabeel ^a,b,c   Welch, Ian ^c   Grange, Robert ^d   Hadway, Jennifer ^a,b   Dhanvantari, Savita ^a,c   Hill, David ^a   Lee, Ting Yim ^a,b,c,e   Hoffman, Lisa M ^a,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; FLUORODEOXYGLUCOSE F 18; UTROPHIN; BIOLOGICAL MARKER;

ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD VOLUME; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; EXERCISE; EXPERIMENTAL MODEL; GLUCOSE METABOLISM; HISTOPATHOLOGY; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE PERFUSION; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; POINT MUTATION; POSITRON EMISSION TOMOGRAPHY; SKELETAL MUSCLE; WILD TYPE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; EVALUATION; GLUCOSE BLOOD LEVEL; LONGITUDINAL STUDY; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; VASCULARIZATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; LONGITUDINAL STUDIES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79957827686     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-127     Document Type: Article

References (50)

1. Function and genetics of dystrophin and dystrophin-related proteins in muscle. DJ Blake A Weir SE Newey KE Davies, Physiol Rev 2002 82 291 329 11917091 (Pubitemid 34654455)
2. The muscular dystrophies. AE Emery, Lancet 2002 359 687 695 10.1016/S0140-6736(02)07815-7 11879882 (Pubitemid 34203773)
3. Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. JM Alderton RA Steinhardt, J Biol Chem 2000 275 9452 9460 10.1074/jbc.275.13.9452 10734092 (Pubitemid 30185173)
4. Calcium homeostasis in dystrophic muscle. UT Ruegg JM Gillis, Trends Pharmacol Sci 1999 20 351 352 10.1016/S0165-6147(99)01377-2 10515794 (Pubitemid 29421612)
5. Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis. TA Rando, Microsc Res Tech 2001 55 223 235 10.1002/jemt.1172 11748861 (Pubitemid 33136322)
6. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. M Sander B Chavoshan SA Harris ST Iannaccone JT Stull GD Thomas RG Victor, Proc Natl Acad Sci USA 2000 97 13818 13823 10.1073/pnas.250379497 11087833
7. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. GD Thomas M Sander KS Lau PL Huang JT Stull RG Victor, Proc Natl Acad Sci USA 1998 95 15090 15095 10.1073/pnas.95.25. 15090 9844020 (Pubitemid 29003761)
8. Nitric oxide as a messenger molecule for myoblast fusion. KH Lee MY Baek KY Moon WK Song CH Chung DB Ha MS Kang, J Biol Chem 1994 269 14371 14374 7514168 (Pubitemid 24193984)
9. Nitric oxide in skeletal muscle. L Kobzik MB Reid DS Bredt JS Stamler, Nature 1994 372 546 548 10.1038/372546a0 7527495 (Pubitemid 24368535)
10. transport in skeletal muscle is nitric oxide dependent. CK Roberts RJ Barnard SH Scheck TW Balon, Am J Physiol 1997 273 220 E225 9252500
11. Do immune cells promote the pathology of dystrophin-deficient myopathies MJ Spencer JG Tidball, Neuromuscul Disord 2001 11 556 564 10.1016/S0960-8966(01) 00198-5 11525885 (Pubitemid 32761799)
12. Diagnosis of dystrophinopathies: review for the clinician. G Miller HB Wessel, Pediatr Neurol 1993 9 3 9 10.1016/0887-8994(93)90002-T 8452597 (Pubitemid 23070089)
13. Serial manual muscle testing in Duchenne muscular dystrophy. DD Kilmer RT Abresch WM Fowler Jr, Arch Phys Med Rehabil 1993 74 1168 1171 8239956 (Pubitemid 23315101)
14. Serum enzymes in disease of skeletal muscle. S Rosalki, Clin Lab Med 1989 9 767 781 2686911 (Pubitemid 20021138)
15. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. EP Hoffman KH Fischbeck M Brown RH Johnson R Medori JD Loire JB Harris R Waterston M Brooke L Specht W Kupsky J Chamberlain CT Caskey F Shapiro LM Kunkel, N Engl J Med 1988 318 1363 1368 10.1056/NEJM198805263182104 3285207
16. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. LM McIntosh RE Baker JE Anderson, Biochem Cell Biol 1998 76 532 541 10.1139/o98-033 9923723 (Pubitemid 29102039)
17. Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. V Straub KM Donahue V Allamand RL Davisson YR Kim KP Campbell, Magn Reson Med 2000 44 655 659 10.1002/1522-2594(200010)4 4:4<655::AID-MRM223.0.CO;2-T 11025524
18. Cardiac function, metabolism and perfusion in Duchenne and Becker muscular dystrophy. RM Quinlivan P Lewis P Marsden R Dundas SA Robb E Baker M Maisey, Neuromuscul Disord 1996 6 237 246 10.1016/0960-8966(96)00007-7 8887952 (Pubitemid 26325319)
19. The alteration of calcium homeostasis in adult dystrophic skeletal muscle fibers is worsened by a chronic exercise in vivo. B Fraysse A Liantonio M Citrone R Burdi S Pierno A Frigeri M Pisoni C Camerino A De Luca, Neurobiol Dis 2004 17 144Y154
20. Functional CT: Physiological models. TY Lee, Trend in Biotech 2002 20 3 s10
21. CT imaging of angiogenesis. TY Lee TG Purdie E Stewart, J Nucl Med 2003 47 171 187 (Pubitemid 37279154)
22. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. KS St Lawrence TY Lee, J Cereb Blood Flow Metab 1998 18 1365 1377 9850149 (Pubitemid 28559684)
23. Anatomy of SUV. Standardized uptake value. SC Huang, Nucl Med Biol 2000 27 643 646 10.1016/S0969-8051(00)00155-4 11091106
24. SUV: standard uptake or silly useless value JW Keyes Jr, J Nucl Med 1995 36 1836 1839 7562051
25. Selected histochemical and histopathological methods. S Thompson, Springfield, IL, Thomas CC, 1966 1639
26. Myogenic satellite cells: physiology to molecular biology. TJ Hawke DJ Garry, J Appl Physiol 2001 91 534 551 11457764 (Pubitemid 32681081)
27. Cellular and molecular regulation of muscle regeneration. S Charge MA Rudnicki, Physiol Rev 2004 84 209 238 10.1152/physrev.00019.2003 14715915 (Pubitemid 38049880)
28. Mechanical stress activates the nuclear factor-B pathway in skeletal muscle fibers: A possible role in Duchenne muscular dystrophy. A Kumar AM Boriek, FASEB J 2003 17 386 96 10.1096/fj.02-0542com 12631578
29. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. A Kumar N Khandelwal R Malya MB Reid AM Boriek, FASEB J 2004 18 102 13 10.1096/fj.03-0453com 14718391 (Pubitemid 38076470)
30. Persistent over-expression of specific CC class chemokines correlates with macrophage and T cell recruitment in mdx skeletal muscle. JD Porter W Guo AP Merriam S Khanna G Cheng X Zhou FH Andrade C Richmonds HJ Kaminski, Neuromuscul Disord 2003 13 223 35 10.1016/s0960-8966(02)00242-0 12609504 (Pubitemid 36279427)
31. Helper (CD4-) and cytotoxic (CD8-) T cells promote the pathology of dystrophin-deficient muscle. MJ Spencer E Montecino-Rodriguez K Dorshkind JG Tidball, Clin Immunol 2001 98 235 43 10.1006/clim.2000.4966 11161980
32. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. M Wehling MJ Spencer JG Tidball, J Cell Biol 2001 155 123 32 10.1083/jcb.200105110 11581289
33. Early onset of inflammation and later involvement of TGF- in Duchenne muscular dystrophy. YW Chen K Nagaraju M Bakay O McIntyre R Rawat R Shi EP Hoffman, Neurology 2005 65 826 34 10.1212/01.wnl.0000173836.09176.c4 16093456 (Pubitemid 41362124)
34. Gene expression profiling in the early phases of DMD: A constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. M Pescatori A Broccolini C Minetti E Bertini C Bruno A D'amico C Bernardini M Mirabella G Silvestri V Giglio A Modoni M Pedemonte G Tasca G Galluzzi E Mercuri PA Tonali E Ricci, FASEB J 2007 21 1210 26 10.1096/fj.06-7285com 17264171 (Pubitemid 46495710)
35. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. JD Porter S Khanna HJ Kaminski JS Rao AP Merriam CR Richmonds P Leahy J Li W Guo FH Andrade, Hum Mol Genet 2002 11 263 72 10.1093/hmg/11.3.263 11823445 (Pubitemid 34173355)
36. Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. R Turk E Sterrenburg EJ de Meijer GJ van Ommen JT den Dunnen PA t Hoen, BMC Genomics 2005 6 98 10.1186/1471-2164-6-98 16011810
37. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy. DR Claflin S Brooks, Am J Physiol Cell Physiol 2008 294 651 658 18171725
38. Functional regeneration in hind limb skeletal muscle of the mdx mouse. JE Andersson BH Bressle WK Ovalle, J Muscle Res Cell Motil 1998 499 515
39. Pathogenesis of neurodegenerative disorders. MP Mattson, Contemporary Neuroscience, Humana, Totowa, NJ, 2001, 294
40. Fiber regeneration is not persistent in dystrophic (mdx) mouse skeletal muscle. JX DiMario A Uzman RC Strohman, Dev Biol 1991 148 314 21 10.1016/0012-1606(91)90340-9 1936568 (Pubitemid 121004770)
41. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. J Tinsley N Deconinck R Fisher D Kahn S Phelps J-M Gillis K Davies, Nat Med 1998 4 1441 1444 10.1038/4033 9846586 (Pubitemid 28553471)
42. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. AE Deconinck AC Potter JM Tinsley SJ Wood R Vater C Young L Metzinger A Vincent CR Slater KE Davies, J Cell Biol 1997 136 883 894 10.1083/jcb.136.4.883 9049253 (Pubitemid 27098744)
43. Chronic exercise accelerates the degeneration-regeneration cycle and downregulates insulin-like groth factor-1 in muscle of mdx mice. T Okano K Yoshida A Nakamura F Sasazawa T Oide S Takeda S Ikeda, Muscle Nerve 2005 32 191 199 10.1002/mus.20351 15937872 (Pubitemid 41061492)
44. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. GT Carter MA Wineinger SA Walsh SJ Horasek RT Abresch WM Fowler Jr, Neuromuscul Disord 1995 5 323 332 10.1016/0960-8966(94)00063-F 7580246
45. Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle. A Hayes DA Williams, J Appl Physiol 1996 80 670 679 8929614 (Pubitemid 26061476)
46. Adaptive and nonadaptive responses to voluntary wheel running by mdx mice. RM Landisch AM Kosir SA Nelson KA Baltgalvis DA Lowe, Muscle Nerve 2008 38 1290 1303 10.1002/mus.21141 18816601
47. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. MA Wineinger RT Abresch SA Walsh GT Carter, Am J Phys Med Rehabil 1998 77 20 27 10.1097/00002060-199801000-00004 9482375 (Pubitemid 28113366)
48. A model for capillary exchange. JA Johnson TA Wilson, Am J Physiol 1966 210 1299 1303 5923068
49. On the theory of the indicator-dilution method for measurement of blood flow and volume. P Meier K Zierler, J Appl Physiol 1954 6 731 744 13174454
50. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. EM Renkin, Am J Physiol 1959 197 1205 1210 14437359